Condition
Hantavirus Infections
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting2
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07358910Recruiting
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
NCT04323904RecruitingPrimary
Hantavirus Registry - HantaReg
NCT00533767TerminatedPrimary
Hantavirus Transmission in Households in Chile
NCT00128180Phase 2CompletedPrimary
Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome
Showing all 4 trials